Live Breaking News & Updates on Respiratory diseases direct admission

Stay informed with the latest breaking news from Respiratory diseases direct admission on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Respiratory diseases direct admission and stay connected to the pulse of your community

23 states where virus activity remains high

CDC data shows downward trend in respiratory virus visits to ERs, but overall activity remains elevated. Some states still experiencing high levels, while majo

Colorado , United-states , New-hampshire , Mississippi , Massachusetts , Wyoming , Louisiana , South-carolina , New-mexico , Georgia , Oklahoma , Rhode-island

18 states where virus activity is still high

18 states where virus activity is still high
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Arkansas , Wyoming , Ohio , Louisiana , Kentucky , New-mexico , Colorado , New-jersey , South-carolina , Massachusetts

Scientists identify a pathway for lung repair after viral infection

A common molecular pathway associated with lung fibrosis may also hold the key to pulmonary vascular repair. A group of scientists at the University of Pennsylvania (Penn) found that when a viral infection damaged these vessels, the injury could be restored by activating the transforming growth factor-β receptor 2 (TGF-βR2) in endothelial cells, which led to cell proliferation.

University-of-pennsylvania-penn , Bioworld-science , Respiratory , University-of-pennsylvania , Influenza , Sars-cov-2 , Tgf-β , Endothelial-cells , Tgf-βr2 , Lung-repair , Infection

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

Georgia , United-states , University-of-georgia , Georgia-state-university , Michal-kuczma , Carolinm-lieber , Vul-ngo , Richard-plemper , Andrew-gewirtz , Kaori-sakamoto , Translational-antiviral-research-at-georgia , Institute-for-biomedical-sciences

Philips consent decree with FDA will halt sales of sleep apnea devices

Royal Philips NV agreed with the U.S. FDA to the terms of a consent decree focused on its Respironics business, following the recall of millions of its devices over the last few years. Although the details of the decree are being finalized, Philips said it will halt the sales of new continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) sleep therapy machines as well as other respiratory care devices in the U.S. until the conditions of the decree are met.

Philips , Respironics , Royal-philips , Bioworld-medtech , Royal-philips-nv , Cpap , Sleep-apnea , Consent-decree , Doj , Regulatory , Fda

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections.

Luxembourg , European-union , European-centre-for-disease-prevention , Disease-prevention , European-economic-area , Respiratory , Espiratory-syncytial-virus , Irus , Ntibody , Hildren , Aboratory

Philips Reaches Agreement With FDA on Ventilator Recall -- 2nd Update

By Elena Vardon Royal Philips reached an agreement with the U.S. Food and Drug Administration on the terms of a settlement linked to recall of its...

Amsterdam , Noord-holland , Netherlands , United-states , American , Dutch , Marc-hesselink , Elena-vardon , Philips-respironics , Roy-jakobs , Philips , Respironics

Inhibrx, Sanofi ratify $2.2B deal for AATD therapy

Inhibrx Inc. and Sanofi SA have agreed to a deal worth up to $2.2 billion, whereby the latter’s Aventis Inc. subsidiary will acquire INBRX-101, an optimized, recombinant alpha-1 antitrypsin (AAT) augmentation therapy undergoing a registrational trial for AAT deficiency (AATD), an inherited genetic disorder caused by single nucleotide variants in the SERPINA1 gene.

Aventis-inc , Inhibrx-inc , Inhibrx-inc- , Sanofi-sa , Inbrx-101 , Aventis-inc- , Alpha-1-antitrypsin-deficiency , Bioworld , Deals-andm-amp-a , Respiratory , Aat-deficiency

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus.

Los-angeles , California , United-states , Brazil , Rio-de-janeiro , Estado-do-rio , Jae-jung , Mary-cambou , Tamiris-azamor , Sophia-paiola , Karin-nielsen , Tara-kerin